The development of the animal model of diabetic retinopathy by the control of the retina-specific VEGF expression
通过控制视网膜特异性VEGF表达建立糖尿病视网膜病变动物模型
基本信息
- 批准号:12671714
- 负责人:
- 金额:$ 2.18万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:2000
- 资助国家:日本
- 起止时间:2000 至 2001
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Transgenic mice with vascular endothelial growth factor (VEGF) driven by the rhodopsin promoter (rho/VEGF mice) develop neovascularization that originates from the deep capillary bed of the retina and grows into the subretinal space. In rho/VEGF mice, VEGF expression in photoreceptors begins between postnatal days 5 and 7, the period when the deep capillary bed is developing. An important question is whether or not the developmental stage of the deep capillary bed is critical for occurrence of neovascularization. Also, although rho/VEGF mice are extremely useful for the study of ocular neovascularization, there are some applications for which the early onset of VEGF expression is a disadvantage. In this study, we used the reverse tetracycline transactivator (rtTA) inducible promoter system coupled to the promoter to control the time of onset of VEGF transgene expression in photoreceptors. In the absence of doxycycline, adult double-transgenic rho/rtTA-TRE/VEGF mice showed little VEGF t … More ransgene expression and no phenotype. The addition of doxycycline to the drinking water resulted in prominent transgene expression and evidence of neovascularization within 3 to 4 days. Like rho/VEGF mice, the neovascularization originated from the deep capillary bed of the retina, but it was more extensive and caused outer retinal folds followed by total retinal detachment. Real-time polymerase chain reaction and enzyme-linked immunosorbent assay demonstrated that the mice with inducible expression of VEGF that developed retinal detachment had much higher ocular levels of VEGF mRNA and protein compared to rho/VEGF mice that manifest a much milder phenotype. These data demonstrate that regardless of developmental stage of the vascular bed, increased expression of VEGF in the retina is sufficient to cause neovascularization, and high levels of expression cause severe neovascularization and traction retinal detachment. Mice with inducible expression of VEGF in the retina provide a valuable new model of ocular neovascularization including diabetic retinopathy. Less
具有由视紫红质启动子驱动的血管内皮生长因子(VEGF)的转基因小鼠(rho/VEGF小鼠)产生源自视网膜深毛细血管床并生长到视网膜下腔的新血管形成。在rho/VEGF小鼠中,光感受器中的VEGF表达开始于出生后第5天至第7天,此时深毛细血管床正在发育。一个重要的问题是深毛细血管床的发育阶段是否是新生血管发生的关键。此外,尽管rho/VEGF小鼠对于眼部新生血管形成的研究非常有用,但是对于某些应用,VEGF表达的早期发作是不利的。在这项研究中,我们使用的反向四环素反式激活因子(rtTA)诱导型启动子系统耦合到启动子控制的时间开始的VEGF转基因表达的感光细胞。在没有强力霉素的情况下,成年双转基因rho/rtTA-TRE/VEGF小鼠显示很少的VEGF表达。 ...更多信息 转基因表达和无表型。在饮用水中添加强力霉素导致显著的转基因表达和3至4天内的新血管形成的证据。与rho/VEGF小鼠一样,新血管形成起源于视网膜的深毛细血管床,但它更广泛,并引起外视网膜褶皱,随后发生完全视网膜脱离。实时聚合酶链反应和酶联免疫吸附试验表明,与表现出更温和的表型的rho/VEGF小鼠相比,具有可诱导VEGF表达的小鼠发展为视网膜脱离,具有更高的VEGF mRNA和蛋白质的眼部水平。这些数据表明,无论血管床的发育阶段如何,视网膜中VEGF表达的增加足以引起新生血管形成,并且高水平的表达引起严重的新生血管形成和牵引性视网膜脱离。在视网膜中具有可诱导的VEGF表达的小鼠提供了包括糖尿病视网膜病变在内的眼部新生血管形成的有价值的新模型。少
项目成果
期刊论文数量(21)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Stanley A.Vinores, et al.: "Sensitivity of different vascular beds in the eye to neovascularization and blood-retinal barrier breakdown in VEGF transgenic mice"Adv Exp Med Biol.. 476. 129-138 (2000)
Stanley A.Vinores 等人:“VEGF 转基因小鼠眼中不同血管床对新生血管形成和血视网膜屏障破坏的敏感性”Adv Exp Med Biol.. 476. 129-138 (2000)
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Kyoko Ohno-Matsui, et al.: "Inducible expression of vascular endothelial growth factor in adult mice causes severe proliferative retinopathy and retinal detachment"Am J Pathol. 160.2. 711-719 (2002)
Kyoko Ohno-Matsui 等人:“成年小鼠中血管内皮生长因子的诱导表达导致严重的增殖性视网膜病变和视网膜脱离”Am J Pathol。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Eri Yamada, et al.: "TIMP-1 promotes VEGF-induced neovascularization in the retina"Histol Histopathol.. 16. 87-97 (2001)
Eri Yamada 等:“TIMP-1 促进 VEGF 诱导的视网膜新生血管形成”Histol Histopathol.. 16. 87-97 (2001)
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Kyoko Ohno-Matsui, et al.: "Increased expression of vascular endothelial growth factor (VEGF) in photoreceptors of adult mice in subretinal neovascularization (NV)"Invest Ophthalmol Vis Sci. 41. S835 (2000)
Kyoko Ohno-Matsui 等人:“视网膜下新生血管 (NV) 成年小鼠光感受器中血管内皮生长因子 (VEGF) 的表达增加”Invest Ophasemol Vis Sci。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Kwak N, Okamoto N, et al.: "VEGF is major stimulator in model of choroidal neovascularization"Invest Ophthalmol Vis Sci. 41. 3158-64 (2000)
Kwak N、Okamoto N 等人:“VEGF 是脉络膜新生血管模型中的主要刺激物”Invest Ophamol Vis Sci。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
OKAMOTO Naoyuki其他文献
OKAMOTO Naoyuki的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('OKAMOTO Naoyuki', 18)}}的其他基金
ALTERNATIVE METHOD FOR THE DIAGNOSIS OF EARLY CANCER USING PLASMA FREE AMINO ACID PROFILES
使用血浆游离氨基酸谱诊断早期癌症的替代方法
- 批准号:
17390195 - 财政年份:2005
- 资助金额:
$ 2.18万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
相似海外基金
Novel Long-Acting Inhibitors of Vascular Endothelial Growth Factor (VEGF) for Treatment of Intraocular Vascular Disorders
用于治疗眼内血管疾病的新型长效血管内皮生长因子 (VEGF) 抑制剂
- 批准号:
10374056 - 财政年份:2020
- 资助金额:
$ 2.18万 - 项目类别:
Novel Long-Acting Inhibitors of Vascular Endothelial Growth Factor (VEGF) for Treatment of Intraocular Vascular Disorders
用于治疗眼内血管疾病的新型长效血管内皮生长因子 (VEGF) 抑制剂
- 批准号:
10610820 - 财政年份:2020
- 资助金额:
$ 2.18万 - 项目类别:
Bioresponsive theranostics for activity on demand delivery of Vascular Endothelial Growth Factor (VEGF)
用于按需输送血管内皮生长因子 (VEGF) 的生物反应性治疗诊断学
- 批准号:
399329442 - 财政年份:2018
- 资助金额:
$ 2.18万 - 项目类别:
Research Grants
Effect of Vascular Endothelial Growth Factor (VEGF) on physiological polymorphism of bone metabolism
血管内皮生长因子(VEGF)对骨代谢生理多态性的影响
- 批准号:
17K07593 - 财政年份:2017
- 资助金额:
$ 2.18万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Regulation of the renal epithelial sodium channel (ENaC) by the vascular endothelial growth factor (VEGF) and the pathogenetic role of renal ENaC for VEGF receptor inhibitor-induced hypertension.
血管内皮生长因子 (VEGF) 对肾上皮钠通道 (ENaC) 的调节以及肾 ENaC 对 VEGF 受体抑制剂诱导的高血压的发病作用。
- 批准号:
288511211 - 财政年份:2016
- 资助金额:
$ 2.18万 - 项目类别:
Research Grants
Metabolic remodeling of glioblastoma by vascular endothelial growth factor (VEGF) inhibitor Bevacizumab
血管内皮生长因子(VEGF)抑制剂贝伐珠单抗对胶质母细胞瘤的代谢重塑
- 批准号:
16K20010 - 财政年份:2016
- 资助金额:
$ 2.18万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
Neuropilin-1 as mediator for Vascular Endothelial Growth Factor (VEGF)-dependent T cell migration
Neuropilin-1 作为血管内皮生长因子 (VEGF) 依赖性 T 细胞迁移的介质
- 批准号:
237773923 - 财政年份:2013
- 资助金额:
$ 2.18万 - 项目类别:
Research Grants
The paracrine and autocrine roles of Vascular Endothelial Growth Factor (VEGF) in ischemic skeletal muscle and endothelial cells.
血管内皮生长因子(VEGF)在缺血骨骼肌和内皮细胞中的旁分泌和自分泌作用。
- 批准号:
443807-2013 - 财政年份:2013
- 资助金额:
$ 2.18万 - 项目类别:
Alexander Graham Bell Canada Graduate Scholarships - Master's
Pathogenesis of intervertebral disc degeneration and functional analysis of vascular endothelial growth factor (VEGF) in the intervertebral disc
椎间盘退变的发病机制及椎间盘血管内皮生长因子(VEGF)的功能分析
- 批准号:
24791570 - 财政年份:2012
- 资助金额:
$ 2.18万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
Clinical study of anti-vascular endothelial growth factor(VEGF) therapy
抗血管内皮生长因子(VEGF)治疗的临床研究
- 批准号:
23591608 - 财政年份:2011
- 资助金额:
$ 2.18万 - 项目类别:
Grant-in-Aid for Scientific Research (C)